Traditional Chinese medicine leader Yuyantang finds tonic in aging population
The company has filed for a Hong Kong IPO, thriving on China’s growing silver economy and a steady stream of government policies supporting traditional Chinese medicine Key Takeaways: Yuyantang has…
Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
The company will use a majority of the $68 million it raised from its Hong Kong listing to expand its network of traditional Chinese medicine hospitals and clinics Key Takeaways:…
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
One of China’s oldest medical names has applied to list its Tong Ren Tang Healthcare Investment unit, which is building an integrated healthcare system Key Takeaways: Top-rated non-public traditional Chinese…
Anew Health taps investor ‘Qi’ with Nasdaq listing plan
The Hong Kong-based provider of pain relief services using traditional Chinese principles aims to raise about $7.2 million through its U.S. listing, valuing it at up to $200 million Key…
Neautus looks outward to boost its traditional medicine story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…
TCMTech fuses old with the new by mixing AI and Chinese medicine
China’s biggest provider of AI-empowered healthcare services using traditional Chinese medicine has filed for a Hong Kong IPO Key Takeaways: TCMTech has filed to list in Hong Kong, reporting its…
BRIEF: China Traditional Chinese Medicine’s profit tumbles in 2024
China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted…
Recent Articles
RELATED ARTICLES
-
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
2667.HK
- Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
-
JBM Healthcare gets bitter pill from investors on anemic performance
2161.HK
- Gushengtang steps up TCM buying spree, doubling down in Beijing
- Investors flee Yan Palace as aging brand struggles to find new audience
-
Confined to Hong Kong, Lung Fung lacks tonic for growth-hungry investors
2290.HK
